Latest News

Filters

Filter by tags: Radiopharmaceutical United States Clear all tag filters

5 news articles found

TerraPower Isotopes and Belgian joint venture PanTera have announced a collaboration to increase the global availability of actinium-225 (Ac-225), while Arizona-based Serva Energy has developed a new research reactor-based production method to ramp up the supply of the rare radioisotope.

Source: World Nuclear News
Date: Wednesday, 28 June 2023
Original article: world-nuclear-news.org/Articles/Nuclear-innovation-companies-in-new-Ac-225-initiat

Australia’s Radiopharm Theranostics and US-based TerraPower have announced an agreement to advance the next generation of radiopharmaceutical therapies for cancer treatment.

Source: NEI Magazine
Date: Thursday, 10 February 2022
Original article: neimagazine.com/news/newsradiopharm-and-terrapower-to-supply-actinium-225-9472292

The nuclear medicine sector is a small part of the wider nuclear industry, but it provides some of the most pioneering technologies in healthcare - and is close to making personalised medicine a reality. Antonis Kalemis, president of Nuclear Medicine Europe and business manager for molecular imaging at Siemens Healthineers, describes how nuclear medicine also tackles the most trenchant condition in modern healthcare: cancer.

Source: World Nuclear News
Date: Thursday, 29 July 2021
Original article: world-nuclear-news.org/Articles/Viewpoint-Nuclear-medicine-is-crucial-for-fighting

Agency schedules webinar and warns of possible shortages at hospitals A researcher at Indonesia’s National Nuclear Agency using a hot cell to prepare a radiopharmaceutical. Courtesy M. Gaspar/IAEA. The production of radioisotopes used to produce radiopharmaceuticals for medical procedures has continued during the Covid-19 pandemic, but hospitals could face shortages due to bottlenecks in transport and distribution, the International Atomic Energy Agency has warned.

An agency survey conducted among operators of research reactors that produce radioisotopes for radiopharmaceuticals shows that most major actors continue to produce radioisotopes because the production facilities have been defined as essential by the relevant governments.

However, many airlines are no longer operating because of the pandemic and borders are closed, which affects the distribution of medical radioisotopes around the world.

Joao Osso Junior, head of the radioisotope products and radiation technology section at the IAEA, said the agency is working to assess the need for medical radioisotopes because most research and education activities using isotopes have been put on hold and many hospitals have delayed diagnosis applications.

Source: Nucnet
Date: Wednesday, 22 April 2020
Original article: nucnet.org/news/radioisotope-industry-facing-distribution-challenges-says-iaea-4-2-2020

Three recent announcements will help secure future supplies of vital medical radioisotopes. Westinghouse Electric Company and Nordion (Canada) Inc are to work together on technology to produce cobalt-60 in pressurised water reactors (PWRs); Framatome and Kinectrics have launched a new joint venture to produce lutetium-177 in partnership with Bruce Power; and BWXT Technologies' proprietary technetium-99m generators have passed a testing milestone.

Source: World Nuclear News
Date: Saturday, 29 February 2020
Original article: world-nuclear-news.org/Articles/Companies-work-on-securing-medical-isotope-supplie